JNCCN 360

Advertisement

Advertisement

Natalie S. Callander, MD, on Newly Diagnosed Multiple Myeloma: What Early-Phase Trials Suggest

Roisin M. Connolly, MD, on Yearly Review of Breast Cancer Treatment Advances

Stephanie Andrews, MS, ANP-BC, on Managing Toxicities of Immunotherapies

Recent

TAT 2020: IL-18 and Anticancer Immunity in Prostate Cancer

Head/Neck Cancers Symposium 2020: Immunotherapy Plus TKIs in Metastatic Thyroid Cancer

New Receptor Protein May Successfully Target Multiple Myeloma Cells

RTK Inhibitor Plus Immunotherapy in Advanced Kidney Cancer

Published

Medical Literature

Sequential Combination Therapy for Chronic Lymphocytic Leukemia

Predicting Relapse of Stage III Melanoma Using Circulating Tumor Cells

Tumor Mutation Burden in Metastatic NSCLC: Predictive of Response to Pembrolizumab?

Moxetumomab Pasudotox Therapy Under Study in Resistant Hairy Cell Leukemia

Ongoing

Emerging Considerations in Triple-Negative Breast Cancer: Focus on Immunotherapy

BCOP Test-Advances in Targeted Therapy and Immunotherapy For The Treatment of Kidney Cancer

NCCN Pharmacy Updates: Advances in Targeted Therapy and Immunotherapy for the Treatment of Kidney Cancer

Consensus or Controversy? Radiation and Medical Oncology Investigator Perspectives on the Role of Immune Checkpoint Inhibition in the Management of Locally Advanced Non–Small Cell Lung Cancer

Available

Clinical Trials

Immunotherapy Clinical Trials at Fred Hutch Cancer Research Center

ClinicalTrials.gov Immunotherapy

Center for Immunotherapy Clinical Research Trials

Cancer Research Institute Immunotherapy Clinical Trials

NCCN Resources

Copyright © 2020 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.